Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GLIOBLASTOMA MULTIFORME”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01873469
What this trial is testing

Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Technische Universität Dresden 102
Early research (Phase 1)Active Not RecruitingNCT04165941
What this trial is testing

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain Tumor Adult
University of Alabama at Birmingham 22
Testing effectiveness (Phase 2)Study completedNCT00085566
What this trial is testing

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Who this might be right for
Brain and Central Nervous System TumorsProstate Cancer
Memorial Sloan Kettering Cancer Center 61
Not applicableActive Not RecruitingNCT07674095
What this trial is testing

Assessment of a Large US EHR Database as Meeting FDA Fit-for-Purpose Requirements to Provide External Controls for Study BPM31510 in Participants With Glioblastoma

Who this might be right for
Glioblastoma
BPGbio 150
Testing effectiveness (Phase 2)Study completedNCT04013672
What this trial is testing

Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence

Who this might be right for
Recurrent Glioblastoma
David Peereboom 41
Testing effectiveness (Phase 2)Looking for participantsNCT07569042
What this trial is testing

A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Malignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 15
Not applicableStudy completedNCT04810182
What this trial is testing

Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Who this might be right for
Glioblastoma Multiforme
Istituto Oncologico Veneto IRCCS 192
Early research (Phase 1)Looking for participantsNCT05577091
What this trial is testing

Tris-CAR-T Cell Therapy for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Beijing Tiantan Hospital 10
Testing effectiveness (Phase 2)UnknownNCT05820191
What this trial is testing

B-amyloid as a Marker for GBM Bioimaging

Who this might be right for
Glioblastoma
Universidad Central del Caribe 3
Early research (Phase 1)Active Not RecruitingNCT02062827
What this trial is testing

Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma

Who this might be right for
Recurrent Glioblastoma MultiformeProgressive Glioblastoma MultiformeAnaplastic Astrocytoma or Gliosarcoma
University of Alabama at Birmingham 29
Early research (Phase 1)Active Not RecruitingNCT05222802
What this trial is testing

Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)

Who this might be right for
Glioblastoma Multiforme
Katmai Pharmaceuticals Inc. 52
Testing effectiveness (Phase 2)Study completedNCT00267592
What this trial is testing

Safety and Efficacy of Talampanel in Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Teva Branded Pharmaceutical Products R&D, Inc. 72
Early research (Phase 1)Ended earlyNCT03283631
What this trial is testing

Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM

Who this might be right for
Recurrent GlioblastomaRecurrent Gliosarcoma
Gary Archer Ph.D. 2
Not applicableStudy completedNCT00780819
What this trial is testing

Borderzone Sampling

Who this might be right for
High Grade GliomaGlioblastoma
Maastricht University Medical Center 10
Not applicableNot Yet RecruitingNCT07366892
What this trial is testing

Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use

Who this might be right for
Suspected Grade III and IV Gliomas Requiring Surgical InterventionNeurosurgical ProcedureGlioma+1 more
Leica Microsystems (Schweiz) AG 37
Not applicableLooking for participantsNCT05500612
What this trial is testing

MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy

Who this might be right for
Glioblastoma Multiforme
University of Sydney 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04959500
What this trial is testing

Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Sun Yat-sen University 150
Not applicableStudy completedNCT01836536
What this trial is testing

Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients

Who this might be right for
GlioblastomaGlioma
Center Eugene Marquis 30
Not applicableLooking for participantsNCT06466031
What this trial is testing

Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO]

Who this might be right for
Glioblastoma Multiforme
Copernicus Memorial Hospital 189
Testing effectiveness (Phase 2)Study completedNCT00612430
What this trial is testing

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Who this might be right for
GlioblastomaGliosarcoma
Duke University 59
Next Page